News Conference News TCT 2021 Good Long-term Results With FANTOM BVS, but More Data Needed Michael O'Riordan October 21, 2021
News Conference News VIVA 2021 EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions L.A. McKeown October 12, 2021
News Daily News Cardiac Deaths and Adverse Events After PCI Have Declined With Time L.A. McKeown October 05, 2021
News Conference News In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS Shelley Wood August 30, 2021
News Features Expired Cardiac Devices May Do Global Good, but Safety Unknown Yael L. Maxwell August 26, 2021
News Daily News Endpoint Reporting in Medical Journals Needs to Be Revamped: Review Michael O'Riordan August 17, 2021
News Daily News Comparable 10-Year Mortality in Elderly Patients After PCI or CABG: SYNTAXES Michael O'Riordan May 31, 2021
News Conference News EuroPCR 2021 The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages L.A. McKeown May 19, 2021
News Conference News ACC 2021 SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal L.A. McKeown May 16, 2021
News Daily News Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles Michael O'Riordan May 12, 2021
News Conference News ACC 2021 Even With Stent Cards, Patients Often Hazy on PCI Details Years Later Michael O'Riordan May 11, 2021
News Conference News SCAI 2021 Compression Times Cut With Adjunctive Hemostatic Patch After Transradial Procedures Michael O'Riordan May 03, 2021
News Daily News Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials L.A. McKeown April 26, 2021
News Daily News Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail L.A. McKeown April 22, 2021
News Daily News CRT 2021 COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold Michael O'Riordan March 17, 2021
News Daily News No Harm, No Help With Bioabsorbable-Polymer Stents: Registry Michael O'Riordan March 01, 2021
News Daily News Site Investigators Missed Clinical Events in GLOBAL LEADERS Michael O'Riordan February 12, 2021